University of Dundee

Biological Chemistry and Drug Discovery

Short Code: 
BCDD

Synthetic Medicinal Chemist

The School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 900 staff from over 60 countries worldwide the School provides a dynamic, multi-national, collegiate and diverse environment with state-of-the-art laboratory, technology and teaching facilities.

Investment enables Ten Bio to establish new skin testing technology in USA

A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals.

Led by TRICAPITAL LTD and with matched funding from Scottish Enterprise, the investment of £911,000 will enable the company to progress its mission to transform the testing of new pharmaceutical and cosmetic products. Initial launch of the company’s brand will be in the US, where the majority of potential customers are based.

Computational Chemist

The School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 900 staff from over 60 countries worldwide the School provides a dynamic, multi-national, collegiate and diverse environment with state-of-the-art laboratory, technology and teaching facilities.

Team Leader (Structural Chemical Biology, Dundee—Almirall PROTAC collaboration)

We are recruiting a highly motivated Team Leader to lead a new team of five scientists as part of an exciting new drug discovery collaboration between the laboratory of Professor Alessio Ciulli at the University of Dundee, and Almirall (a global pharmaceutical company focused on skin diseases with high level of unmet medical need) and its Research Department located in Barcelona, Spain. Our mission is to discover and develop a class of small-molecule degrader drugs as a novel therapeutic paradigm to treat inflammatory skin diseases.

£38 million investment in University spinout

Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.

Amphista is a biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease-causing proteins. The company is a spinout from Professor Alessio Ciulli’s labs at the University’s School of Life Sciences.

Medicinal Chemistry Team Leader

The School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 900 staff from over 60 countries worldwide the School provides a dynamic, multi-national, collegiate and diverse environment with state-of-the-art laboratory, technology and teaching facilities.

Marie Skłodowska-Curie Fellowship Success for School

In the recent round of applications for Marie Skłodowska-Curie Fellowships, the School had a 100% success rate! Over the coming months, three scientists from across the globe will commence their new research projects. Angus Cowan from Melbourne, Australia and Claudia Diehl from Aachen, Germany will join Professor Alessio Ciulli’s lab while Angela Harrison, also from Melbourne, will join Professor Angus Lamond’s team.

Pages